{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:38:24Z","timestamp":1793234304222,"version":"4.5.0"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U19AI118610"],"award-info":[{"award-number":["U19AI118610"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["P01AI106695"],"award-info":[{"award-number":["P01AI106695"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI099631"],"award-info":[{"award-number":["R01AI099631"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["U54 AI065359"],"award-info":[{"award-number":["U54 AI065359"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","award":["GT16780"],"award-info":[{"award-number":["GT16780"]}],"id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The four dengue virus serotypes (DENV1-4) co-circulate worldwide, posing major challenges for vaccine development. One key issue is that certain levels and subsets of cross-reactive antibodies have been associated with enhanced disease during subsequent infection with a different DENV serotype. To understand the heterogeneity of DENV antibody responses and delineate their distinct kinetics, we define the magnitude and kinetics of 84 antiviral antibody subsets (by isotype, subclass, antigen, and cross-reactivity) after primary versus secondary dengue, using longitudinal samples collected &lt;1, 3, 6 and 18 months post-symptom onset from a pediatric hospital study in Nicaragua. Interestingly, we find that after\u00a0primary infection, cross-reactive IgG antibody responses against the envelope protein rise, not wane, over time. Antibody kinetics vary by specificity as measured by homologous versus cross-reactive subsets, viral antigen, and subdomain of a single antigen. Further, a substantial fraction of subjects still have IgA, IgM, and IgG3 responses above the assay background at 18 months post-infection. Overall, we find that\u00a0the cross-reactive subset of post-primary anti-DENV antibody responses demonstrates distinct kinetics from overall DENV-binding antibodies as well as from secondary immune responses, which has implications for the outcome of subsequent DENV infections.<\/jats:p>","DOI":"10.1038\/s41467-026-74406-0","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T23:32:11Z","timestamp":1781998331000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Longitudinal antibody profiling after dengue reveals distinct dynamics by antibody specificity over 18 months"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5036-0336","authenticated-orcid":false,"given":"Sandra","family":"Bos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7416-7861","authenticated-orcid":false,"given":"Tulika","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0107-6173","authenticated-orcid":false,"given":"Jos\u00e9 Victor","family":"Zambrana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinaldo","family":"Mercado-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8939-1971","authenticated-orcid":false,"given":"Julia","family":"Huffaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2623-7910","authenticated-orcid":false,"given":"Aaron","family":"Graber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Balmaseda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7238-4037","authenticated-orcid":false,"given":"Eva","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,21]]},"reference":[{"key":"74406_CR1","unstructured":"World Health Organization (WHO). Dengue Guidelines for Diagnosis, Treatment, Prevention and Control: New Edition (World Health Organization, Geneva, Switzerland, 2009)."},{"key":"74406_CR2","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax4144","volume":"12","author":"L Cattarino","year":"2020","unstructured":"Cattarino, L., Rodriguez-Barraquer, I., Imai, N., Cummings, D. A. T. & Ferguson, N. M. Mapping global variation in dengue transmission intensity. Sci. Transl. Med. 12, eaax4144 (2020).","journal-title":"Sci. Transl. Med."},{"key":"74406_CR3","doi-asserted-by":"publisher","first-page":"e0007213","DOI":"10.1371\/journal.pntd.0007213","volume":"13","author":"SJ Ryan","year":"2019","unstructured":"Ryan, S. J., Carlson, C. J., Mordecai, E. A. & Johnson, L. R. Global expansion and redistribution of Aedes-borne virus transmission risk with climate change. PLoS Negl. Trop. Dis. 13, e0007213 (2019).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"74406_CR4","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1016\/S1473-3099(16)30473-X","volume":"17","author":"LC Katzelnick","year":"2017","unstructured":"Katzelnick, L. C., Coloma, J. & Harris, E. Dengue: knowledge gaps, unmet needs, and research priorities. Lancet Infect. Dis. 17, e88\u2013e100 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"74406_CR5","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nri3916","volume":"15","author":"G Screaton","year":"2015","unstructured":"Screaton, G., Mongkolsapaya, J., Yacoub, S. & Roberts, C. New insights into the immunopathology and control of dengue virus infection. Nat. Rev. Immunol. 15, 745\u2013759 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"74406_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/infdis\/140.4.527","volume":"140","author":"SB Halstead","year":"1979","unstructured":"Halstead, S. B. In vivo enhancement of dengue virus infection in rhesus monkeys by passively transferred antibody. J. Infect. Dis. 140, 527\u2013533 (1979).","journal-title":"J. Infect. Dis."},{"key":"74406_CR7","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1093\/oxfordjournals.aje.a113932","volume":"120","author":"N Sangkawibha","year":"1984","unstructured":"Sangkawibha, N. et al. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am. J. Epidemiol. 120, 653\u2013669 (1984).","journal-title":"Am. J. Epidemiol."},{"key":"74406_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-023-44330-8","volume":"15","author":"S Bos","year":"2024","unstructured":"Bos, S. et al. Protection against symptomatic dengue infection by neutralizing antibodies varies by infection history and infecting serotype. Nat. Commun. 15, 1\u201313 (2024).","journal-title":"Nat. Commun."},{"key":"74406_CR9","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1073\/pnas.1522136113","volume":"113","author":"LC Katzelnick","year":"2016","unstructured":"Katzelnick, L. C., Montoya, M., Gresh, L., Balmaseda, A. & Harris, E. Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort. Proc. Natl. Acad. Sci. USA 113, 728\u2013733 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74406_CR10","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1128\/mSphere.00528-19","volume":"4","author":"CYY Chan","year":"2019","unstructured":"Chan, C. Y. Y. et al. Antibody-dependent dengue virus entry modulates cell intrinsic responses for enhanced infection. mSphere 4, 528\u2013547 (2019).","journal-title":"mSphere"},{"key":"74406_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004386","volume":"10","author":"R De Alwis","year":"2014","unstructured":"De Alwis, R. et al. Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera. PLoS Pathog. 10, e1004386 (2014).","journal-title":"PLoS Pathog."},{"key":"74406_CR12","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/infdis\/jiz618","volume":"221","author":"JJ Waggoner","year":"2020","unstructured":"Waggoner, J. J. et al. Antibody-dependent enhancement of severe disease is mediated by serum viral load in pediatric dengue virus infections. J. Infect. Dis. 221, 1846\u20131854 (2020).","journal-title":"J. Infect. Dis."},{"key":"74406_CR13","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1128\/microbiolspec.AID-0022-2014","volume":"2","author":"SB Halstead","year":"2014","unstructured":"Halstead, S. B. Dengue antibody-dependent enhancement: knowns and unknowns. Microbiol. Spectr. 2, 249\u2013271 (2014).","journal-title":"Microbiol. Spectr."},{"key":"74406_CR14","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.aan6836","volume":"358","author":"LC Katzelnick","year":"2017","unstructured":"Katzelnick, L. C. et al. Antibody-dependent enhancement of severe dengue disease in humans. Science 358, 929\u2013932 (2017).","journal-title":"Science"},{"key":"74406_CR15","doi-asserted-by":"publisher","first-page":"444","DOI":"10.4269\/ajtmh.1989.40.444","volume":"40","author":"SC Kliks","year":"1989","unstructured":"Kliks, S. C., Nisalak, A., Brandt, W. E., Wahl, L. & Burke, D. S. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 40, 444\u2013451 (1989).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"74406_CR16","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1126\/science.abb6143","volume":"369","author":"LC Katzelnick","year":"2020","unstructured":"Katzelnick, L. C. et al. Zika virus infection enhances future risk of severe dengue disease. Science 369, 1123\u20131128 (2020).","journal-title":"Science"},{"key":"74406_CR17","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3201\/eid2305.161630","volume":"23","author":"MH Collins","year":"2017","unstructured":"Collins, M. H. et al. Lack of durable cross-neutralizing antibodies against Zika virus from dengue virus infection. Emerg. Infect. Dis. 23, 773\u2013781 (2017).","journal-title":"Emerg. Infect. Dis."},{"key":"74406_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007648","volume":"13","author":"T Singh","year":"2019","unstructured":"Singh, T. et al. Efficient transplacental IgG transfer in women infected with Zika virus during pregnancy. PLoS Negl. Trop. Dis. 13, e0007648 (2019).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"74406_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adn2199","volume":"16","author":"JV Zambrana","year":"2024","unstructured":"Zambrana, J. V. et al. Primary exposure to Zika virus is linked with increased risk of symptomatic dengue virus infection with serotypes 2, 3, and 4, but not 1. Sci. Transl. Med. 16, eadn2199 (2024).","journal-title":"Sci. Transl. Med."},{"key":"74406_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011710","volume":"17","author":"CF Estofolete","year":"2023","unstructured":"Estofolete, C. F. et al. Influence of previous Zika virus infection on acute dengue episode. PLoS Negl. Trop. Dis. 17, e0011710 (2023).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"74406_CR21","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/infdis\/jit273","volume":"208","author":"S Olkowski","year":"2013","unstructured":"Olkowski, S. et al. Reduced risk of disease during postsecondary dengue virus infections. J. Infect. Dis. 208, 1026 (2013).","journal-title":"J. Infect. Dis."},{"key":"74406_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.virusres.2017.06.019","volume":"254","author":"DV Andrade","year":"2018","unstructured":"Andrade, D. V. & Harris, E. Recent advances in understanding the adaptive immune response to Zika virus and the effect of previous flavivirus exposure. Virus Res. 254, 27\u201333 (2018).","journal-title":"Virus Res."},{"key":"74406_CR23","doi-asserted-by":"publisher","first-page":"12562","DOI":"10.1128\/JVI.00871-13","volume":"87","author":"W-Y Tsai","year":"2013","unstructured":"Tsai, W.-Y. et al. High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection. J. Virol. 87, 12562\u201312575 (2013).","journal-title":"J. Virol."},{"key":"74406_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005554","volume":"11","author":"B Patel","year":"2017","unstructured":"Patel, B. et al. Dissecting the human serum antibody response to secondary dengue virus infections. PLoS Negl. Trop. Dis. 11, e0005554 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"74406_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12295-2","volume":"10","author":"EX P\u00e9rez-Guzm\u00e1n","year":"2019","unstructured":"P\u00e9rez-Guzm\u00e1n, E. X. et al. Time elapsed between Zika and dengue virus infections affects antibody and T cell responses. Nat. Commun. 10, 4316 (2019).","journal-title":"Nat. Commun."},{"key":"74406_CR26","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/infdis\/jiy164","volume":"218","author":"M Montoya","year":"2018","unstructured":"Montoya, M. et al. Longitudinal analysis of antibody cross-neutralization following Zika virus and dengue virus infection in Asia and the Americas. J. Infect. Dis. 218, 536\u2013545 (2018).","journal-title":"J. Infect. Dis."},{"key":"74406_CR27","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.4269\/ajtmh.14-0132","volume":"91","author":"GE Snow","year":"2014","unstructured":"Snow, G. E., Haaland, B., Ooi, E. E. & Gubler, D. J. Research on dengue during World War II revisited. Am. J. Trop. Med. Hyg. 91, 1203 (2014).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"74406_CR28","doi-asserted-by":"publisher","first-page":"e2357","DOI":"10.1371\/journal.pntd.0002357","volume":"7","author":"M Montoya","year":"2013","unstructured":"Montoya, M. et al. Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year. PLoS Negl. Trop. Dis. 7, e2357 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"74406_CR29","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/infdis\/jit436","volume":"209","author":"KB Anderson","year":"2014","unstructured":"Anderson, K. B. et al. A shorter time interval between first and second dengue infections is associated with protection from clinical illness in a school-based cohort in Thailand. J. Infect. Dis. 209, 360\u2013368 (2014).","journal-title":"J. Infect. Dis."},{"key":"74406_CR30","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/s41586-018-0157-4","volume":"557","author":"H Salje","year":"2018","unstructured":"Salje, H. et al. Reconstruction of antibody dynamics and infection histories to evaluate dengue risk. Nature 557, 719\u2013723 (2018).","journal-title":"Nature"},{"key":"74406_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abg9478","volume":"13","author":"LC Katzelnick","year":"2021","unstructured":"Katzelnick, L. C. et al. Dengue and Zika virus infections in children elicit cross-reactive protective and enhancing antibodies that persist long term. Sci. Transl. Med. 13, eabg9478 (2021).","journal-title":"Sci. Transl. Med."},{"key":"74406_CR32","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1093\/infdis\/jiv759","volume":"213","author":"HE Clapham","year":"2016","unstructured":"Clapham, H. E. et al. Dengue virus (DENV) neutralizing antibody kinetics in children after symptomatic primary and postprimary DENV infection. J. Infect. Dis. 213, 1428\u20131435 (2016).","journal-title":"J. Infect. Dis."},{"key":"74406_CR33","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0065-3527(03)59005-4","volume":"59","author":"JT Roehrig","year":"2003","unstructured":"Roehrig, J. T. Antigenic structure of flavivirus proteins. Adv. Virus Res. 59, 141\u2013175 (2003).","journal-title":"Adv. Virus Res."},{"key":"74406_CR34","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/ni.3058","volume":"16","author":"W Dejnirattisai","year":"2015","unstructured":"Dejnirattisai, W. et al. A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nat. Immunol. 16, 170\u2013177 (2015).","journal-title":"Nat. Immunol."},{"key":"74406_CR35","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.coviro.2020.07.006","volume":"45","author":"M Sevvana","year":"2020","unstructured":"Sevvana, M. & Kuhn, R. J. Mapping the diverse structural landscape of the flavivirus antibody repertoire. Curr. Opin. Virol. 45, 51\u201364 (2020).","journal-title":"Curr. Opin. Virol."},{"key":"74406_CR36","doi-asserted-by":"publisher","first-page":"7439","DOI":"10.1073\/pnas.1200566109","volume":"109","author":"R De Alwis","year":"2012","unstructured":"De Alwis, R. et al. Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proc. Natl. Acad. Sci. USA 109, 7439\u20137444 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74406_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002451","volume":"7","author":"CY Lai","year":"2013","unstructured":"Lai, C. Y. et al. Analysis of cross-reactive antibodies recognizing the fusion loop of envelope protein and correlation with neutralizing antibody titers in Nicaraguan dengue cases. PLoS Negl. Trop. Dis. 7, e2451 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"74406_CR38","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1126\/science.abc0476","volume":"371","author":"SB Biering","year":"2021","unstructured":"Biering, S. B. et al. Structural basis for antibody inhibition of flavivirus NS1\u2013triggered endothelial dysfunction. Science 371, 194\u2013200 (2021).","journal-title":"Science"},{"key":"74406_CR39","doi-asserted-by":"publisher","first-page":"117227","DOI":"10.3389\/fimmu.2014.00520","volume":"5","author":"G Vidarsson","year":"2014","unstructured":"Vidarsson, G., Dekkers, G. & Rispens, T. IgG subclasses and allotypes: From structure to effector functions. Front. Immunol. 5, 117227 (2014).","journal-title":"Front. Immunol."},{"key":"74406_CR40","doi-asserted-by":"publisher","first-page":"4332","DOI":"10.1128\/JCM.39.12.4332-4338.2001","volume":"39","author":"P Koraka","year":"2001","unstructured":"Koraka, P. et al. Kinetics of dengue virus-specific serum immunoglobulin classes and subclasses correlate with clinical outcome of infection. J. Clin. Microbiol. 39, 4332\u20134338 (2001).","journal-title":"J. Clin. Microbiol."},{"key":"74406_CR41","doi-asserted-by":"publisher","first-page":"4826","DOI":"10.1016\/j.cell.2022.10.023","volume":"185","author":"T Singh","year":"2022","unstructured":"Singh, T. et al. A Zika virus-specific IgM elicited in pregnancy exhibits ultrapotent neutralization. Cell 185, 4826\u20134840.e17 (2022).","journal-title":"Cell"},{"key":"74406_CR42","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.3389\/fimmu.2018.02177","volume":"9","author":"B Schiela","year":"2018","unstructured":"Schiela, B. et al. Active human complement reduces the Zika virus load via formation of the membrane-attack complex. Front. Immunol. 9, 2177 (2018).","journal-title":"Front. Immunol."},{"key":"74406_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abm3151","volume":"14","author":"AG Dias","year":"2022","unstructured":"Dias, A. G. et al. Antibody Fc characteristics and effector functions correlate with protection from symptomatic dengue virus type 3 infection. Sci. Transl. Med. 14, eabm3151 (2022).","journal-title":"Sci. Transl. Med."},{"key":"74406_CR44","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41590-025-02363-9","volume":"27","author":"JA Cardona-Ospina","year":"2026","unstructured":"Cardona-Ospina, J. A. et al. IgA-driven neutrophil activation underlies severe dengue disease after primary Zika virus infection in humans. Nat. Immunol. 27, 126\u2013134 (2026).","journal-title":"Nat. Immunol."},{"key":"74406_CR45","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1016\/j.jaci.2018.02.017","volume":"141","author":"E Blanco","year":"2018","unstructured":"Blanco, E. et al. Age-associated distribution of normal B-cell and plasma cell subsets in peripheral blood. J. Allergy Clin. Immunol. 141, 2208\u20132219.e16 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"74406_CR46","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1146\/annurev-immunol-090122-042631","volume":"43","author":"Y Lei","year":"2025","unstructured":"Lei, Y. & Tsang, J. S. Systems human immunology and AI: immune setpoint and immune health. Annu. Rev. Immunol. 43, 693\u2013722 (2025).","journal-title":"Annu. Rev. Immunol."},{"key":"74406_CR47","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4269\/ajtmh.1952.1.30","volume":"1","author":"AB Sabin","year":"1952","unstructured":"Sabin, A. B. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1, 30\u201350 (1952).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"74406_CR48","doi-asserted-by":"publisher","first-page":"e975","DOI":"10.1371\/journal.pntd.0000975","volume":"5","author":"TP Endy","year":"2011","unstructured":"Endy, T. P. et al. Determinants of inapparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand. PLoS Negl. Trop. Dis. 5, e975 (2011).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"74406_CR49","doi-asserted-by":"publisher","first-page":"20130414","DOI":"10.1098\/rsif.2013.0414","volume":"10","author":"NG Reich","year":"2013","unstructured":"Reich, N. G. et al. Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity. J. R. Soc. Interface 10, 20130414 (2013).","journal-title":"J. R. Soc. Interface"},{"key":"74406_CR50","doi-asserted-by":"publisher","first-page":"9535","DOI":"10.1073\/pnas.1120621109","volume":"109","author":"H Salje","year":"2012","unstructured":"Salje, H. et al. Revealing the microscale spatial signature of dengue transmission and immunity in an urban population. Proc. Natl. Acad. Sci. USA 109, 9535\u20139538 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74406_CR51","doi-asserted-by":"publisher","first-page":"100630","DOI":"10.1016\/j.epidem.2022.100630","volume":"41","author":"L L\u00f3pez","year":"2022","unstructured":"L\u00f3pez, L., Paul, R. E., Cao-Lormeau, V. M. & Rod\u00f3, X. Considering waning immunity to better explain dengue dynamics. Epidemics 41, 100630 (2022).","journal-title":"Epidemics"},{"key":"74406_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-1590-z","volume":"15","author":"P Bhoomiboonchoo","year":"2015","unstructured":"Bhoomiboonchoo, P. et al. Sequential dengue virus infections detected in active and passive surveillance programs in Thailand, 1994-2010 disease epidemiology - infectious. BMC Public Health 15, 250 (2015).","journal-title":"BMC Public Health"},{"key":"74406_CR53","doi-asserted-by":"publisher","first-page":"103025","DOI":"10.3389\/fimmu.2014.00388","volume":"5","author":"YX Toh","year":"2014","unstructured":"Toh, Y. X. et al. Dengue serotype cross-reactive, anti-E protein antibodies confound specific immune memory for 1 year after infection. Front. Immunol. 5, 103025 (2014).","journal-title":"Front. Immunol."},{"key":"74406_CR54","doi-asserted-by":"publisher","first-page":"e0005926","DOI":"10.1371\/journal.pntd.0005926","volume":"11","author":"HE Clapham","year":"2017","unstructured":"Clapham, H. E., Cummings, D. A. T. & Johansson, M. A. Immune status alters the probability of apparent illness due to dengue virus infection: evidence from a pooled analysis across multiple cohort and cluster studies. PLoS Negl. Trop. Dis. 11, e0005926 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"74406_CR55","doi-asserted-by":"publisher","first-page":"4987","DOI":"10.3389\/fimmu.2021.777672","volume":"12","author":"AD Wegman","year":"2021","unstructured":"Wegman, A. D. et al. Monomeric IgA antagonizes IgG-mediated enhancement of DENV infection. Front. Immunol. 12, 4987 (2021).","journal-title":"Front. Immunol."},{"key":"74406_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011722","volume":"19","author":"J Lubow","year":"2023","unstructured":"Lubow, J. et al. Single B cell transcriptomics identifies multiple isotypes of broadly neutralizing antibodies against flaviviruses. PLoS Pathog. 19, e1011722 (2023).","journal-title":"PLoS Pathog."},{"key":"74406_CR57","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature14130","volume":"520","author":"A Rouvinski","year":"2015","unstructured":"Rouvinski, A. et al. Recognition determinants of broadly neutralizing human antibodies against dengue viruses. Nature 520, 109\u2013113 (2015).","journal-title":"Nature"},{"key":"74406_CR58","doi-asserted-by":"publisher","first-page":"6052","DOI":"10.1016\/j.cell.2021.11.010","volume":"184","author":"A Sharma","year":"2021","unstructured":"Sharma, A. et al. The epitope arrangement on flavivirus particles contributes to Mab C10\u2019s extraordinary neutralization breadth across Zika and dengue viruses. Cell 184, 6052\u20136066.e18 (2021).","journal-title":"Cell"},{"key":"74406_CR59","doi-asserted-by":"publisher","first-page":"e1226","DOI":"10.1093\/infdis\/jiae299","volume":"230","author":"M Premazzi Papa","year":"2024","unstructured":"Premazzi Papa, M. et al. Dengue NS1 antibodies are associated with clearance of viral nonstructural protein-1. J. Infect. Dis. 230, e1226\u2013e1234 (2024).","journal-title":"J. Infect. Dis."},{"key":"74406_CR60","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1128\/JVI.00844-21","volume":"95","author":"AW Wessel","year":"2021","unstructured":"Wessel, A. W. et al. Levels of circulating NS1 impact West Nile virus spread to the brain. J. Virol. 95, 844\u2013865 (2021).","journal-title":"J. Virol."},{"key":"74406_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1013811","volume":"21","author":"H Puerta-Guardo","year":"2025","unstructured":"Puerta-Guardo, H. et al. Flavivirus NS1-triggered endothelial dysfunction promotes virus dissemination. PLoS Pathog. 21, e1013811 (2025).","journal-title":"PLoS Pathog."},{"key":"74406_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-025-91099-5","volume":"15","author":"DA Muller","year":"2025","unstructured":"Muller, D. A. et al. Kinetics of NS1 and anti-NS1 IgG following dengue infection reveals likely early formation of immune complexes in secondary infected patients. Sci. Rep. 15, 1\u20138 (2025).","journal-title":"Sci. Rep."},{"key":"74406_CR63","doi-asserted-by":"publisher","first-page":"1468871","DOI":"10.3389\/fimmu.2024.1468871","volume":"15","author":"T Singh","year":"2024","unstructured":"Singh, T. et al. Dynamics of cytokine and antibody responses in community versus hospital SARS-CoV-2 infections. Front. Immunol. 15, 1468871 (2024).","journal-title":"Front. Immunol."},{"key":"74406_CR64","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1038\/s41591-023-02582-3","volume":"29","author":"P Schommers","year":"2023","unstructured":"Schommers, P. et al. Dynamics and durability of HIV-1 neutralization are determined by viral replication. Nat. Med. 29, 2763\u20132774 (2023).","journal-title":"Nat. Med."},{"key":"74406_CR65","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/00002030-198904000-00006","volume":"3","author":"P Reiss","year":"1989","unstructured":"Reiss, P. et al. Antibody response to the viral negative factor (nef) in HIV-1 infection: a correlate of levels of HIV-1 expression. AIDS 3, 227\u2013234 (1989).","journal-title":"AIDS"},{"key":"74406_CR66","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41577-019-0143-6","volume":"19","author":"F Krammer","year":"2019","unstructured":"Krammer, F. The human antibody response to influenza A virus infection and vaccination. Nat. Rev. Immunol. 19, 383\u2013397 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"74406_CR67","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/bs.pmbts.2014.10.005","volume":"129","author":"TC Pierson","year":"2015","unstructured":"Pierson, T. C. & Diamond, M. S. A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection. Prog. Mol. Biol. Transl. Sci. 129, 141\u2013166 (2015).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"74406_CR68","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jviromet.2018.04.009","volume":"257","author":"EJM Nascimento","year":"2018","unstructured":"Nascimento, E. J. M. et al. Development of antibody biomarkers of long term and recent dengue virus infections. J. Virol. Methods 257, 62\u201368 (2018).","journal-title":"J. Virol. Methods"},{"key":"74406_CR69","unstructured":"Murphy, K. Fig 5.15. The physical properties of the human immunoglobulin isotypes. In Janeway\u2019s Immunobiology, 8th ed. 174 (Garland Science, New York, 2012)."},{"key":"74406_CR70","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00400-21","volume":"59","author":"AE Calvert","year":"2021","unstructured":"Calvert, A. E. et al. The specificity of the persistent IgM neutralizing antibody response in Zika virus infections among individuals with prior dengue virus exposure. J. Clin. Microbiol. 59, e0040021 (2021).","journal-title":"J. Clin. Microbiol."},{"key":"74406_CR71","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.3201\/eid2512.191022","volume":"25","author":"I Griffin","year":"2019","unstructured":"Griffin, I. et al. Zika virus IGM 25 months after symptom onset, Miami-Dade County, Florida, USA. Emerg. Infect. Dis. 25, 2264\u20132265 (2019).","journal-title":"Emerg. Infect. Dis."},{"key":"74406_CR72","doi-asserted-by":"publisher","first-page":"115613","DOI":"10.1016\/j.celrep.2025.115613","volume":"44","author":"AG Dias","year":"2025","unstructured":"Dias, A. G. et al. Anti-dengue virus antibodies that elicit complement-mediated lysis of Zika virion correlate with protection from severe dengue disease. Cell Rep. 44, 115613 (2025).","journal-title":"Cell Rep."},{"key":"74406_CR73","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ade2798","volume":"8","author":"P Irrgang","year":"2022","unstructured":"Irrgang, P. et al. Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 MRNA vaccination. Sci. Immunol. 8, eade2798 (2022).","journal-title":"Sci. Immunol."},{"key":"74406_CR74","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adi1734","volume":"15","author":"RA Aogo","year":"2023","unstructured":"Aogo, R. A. et al. Effects of boosting and waning in highly exposed populations on dengue epidemic dynamics. Sci. Transl. Med. 15, eadi1734 (2023).","journal-title":"Sci. Transl. Med."},{"key":"74406_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0012811","volume":"19","author":"F Narvaez","year":"2025","unstructured":"Narvaez, F. et al. Dengue severity by serotype and immune status in 19 years of pediatric clinical studies in Nicaragua. PLoS Negl. Trop. Dis. 19, e0012811 (2025).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"74406_CR76","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4269\/ajtmh.2006.74.449","volume":"74","author":"A Balmaseda","year":"2006","unstructured":"Balmaseda, A. et al. Serotype-specific differences in clinical manifestations of dengue. Am. J. Trop. Med. Hyg. 74, 449\u2013456 (2006).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"74406_CR77","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001397","volume":"5","author":"F Narvaez","year":"2011","unstructured":"Narvaez, F. et al. Evaluation of the traditional and revised WHO classifications of dengue disease severity. PLoS Negl. Trop. Dis. 5, e1397 (2011).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"74406_CR78","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4269\/ajtmh.2000.63.5","volume":"63","author":"E Harris","year":"2000","unstructured":"Harris, E. et al. Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am. J. Trop. Med. Hyg. 63, 5\u201311 (2000).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"74406_CR79","doi-asserted-by":"publisher","first-page":"893","DOI":"10.4269\/ajtmh.1999.61.893","volume":"61","author":"A Balmaseda","year":"1999","unstructured":"Balmaseda, A., Sandoval, E., P\u00e9rez, L., Guti\u00e9rrez, C. M. & Harris, E. Application of molecular typing techniques in the 1998 dengue epidemic in Nicaragua. Am. J. Trop. Med. Hyg. 61, 893\u2013897 (1999).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"74406_CR80","doi-asserted-by":"publisher","first-page":"e2385","DOI":"10.1371\/journal.pntd.0002385","volume":"7","author":"G Guti\u00e9rrez","year":"2013","unstructured":"Guti\u00e9rrez, G. et al. Evaluation of the diagnostic utility of the traditional and revised WHO dengue case definitions. PLoS Negl. Trop. Dis. 7, e2385 (2013).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"74406_CR81","unstructured":"World Health Organization (WHO). Dengue Hemorrhagic Fever: Diagnosis, Treatment and Control\u22122nd Ed. (WHO, 1997)."},{"key":"74406_CR82","unstructured":"Van Der Leeden, R., Meijer, E. & Busing, F. M. T. A. Chapter 11. Resampling multilevel models. In Handbook of Multilevel Analysis (eds de Leeuw, J. & Meijer, E.) (Springer, 2008)."},{"key":"74406_CR83","unstructured":"Jose Victor, Z. & Bos, S. R Code, Readme, and Source Data: Longitudinal Antibody Profiling After Dengue Reveals Distinct Dynamics by Antibody Specificity Over 18 Months https:\/\/zenodo.org\/records\/19155076 (2026)."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74406-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74406-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74406-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:05:54Z","timestamp":1785888354000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74406-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74406"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74406-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,21]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"7808"}}